Akso Health Group (AHG) Revenue History
Annual and quarterly revenue from 2015 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
Revenue Growth Metrics
Revenue Breakdown (FY 2022)
AHG's revenue distribution by segment and geography for fiscal year 2022
By Product/Segment
AHG Revenue Analysis (2015–2025)
As of March 1, 2026, Akso Health Group (AHG) generated trailing twelve-month (TTM) revenue of $14.8 million, reflecting explosive growth of +415.8% year-over-year. The most recent quarter (Q4 2025) recorded $3.9 million in revenue, up 0.0% sequentially.
Looking at the longer-term picture, AHG's 5-year compound annual growth rate (CAGR) stands at +16.4%, indicating consistent double-digit revenue growth. The company achieved its highest annual revenue of $107.3 million in 2018.
Revenue diversification analysis shows AHG's business is primarily driven by Interest income (100%). With over half of revenue concentrated in Interest income, the company maintains significant focus in this area while developing other growth vectors.
When compared to Financial Services sector peers including COF, SYF, and SYF-PB. Compare AHG vs COF →
Peer Comparison
Compare AHG's revenue metrics with industry peers
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| AHGCurrent | $15M | +415.8% | +16.4% | -1125.4% | |
| COF | $53.9B | - | - | 11.0% | |
| SYF | $20.8B | - | - | 21.9% | |
| SYF-PB | $20.8B | - | - | 21.9% | |
| OMF | $6.2B | - | - | 37.5% | |
| ENVA | $3.2B | - | - | 23.5% |
Historical Revenue Data
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $14.8M | - | $-281,526 | -1.9% | $-166,304,352 | -1125.4% |
| 2024 | $2.4M | - | $122K | 5.1% | $-8,638,040 | -357.8% |
| 2023 | $13.2M | - | $1.3M | 9.6% | $-14,266,853 | -108.2% |
| 2022 | $6.0M | - | $605K | 10.1% | $-3,260,463 | -54.3% |
| 2021 | $1.8M | - | $1.2M | 69.0% | $-27,149,727 | -1547.1% |
| 2020 | $6.9M | - | $6.9M | 100.0% | $-48,105,690 | -695.7% |
| 2019 | $3.7M | - | $3.7M | 100.0% | $-7,189,188 | -194.6% |
| 2018 | $107.3M | - | $98.8M | 92.1% | $75.9M | 70.7% |
| 2017 | $22.9M | - | $17.8M | 77.5% | $9.9M | 43.3% |
| 2016 | $11.9M | - | $9.5M | 80.2% | $4.1M | 34.8% |
See AHG's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs AHG Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare AHG vs JPM
See how AHG stacks up against sector leader JPMorgan Chase & Co..
Start ComparisonFrequently Asked Questions
Is AHG's revenue growth accelerating or slowing?
AHG revenue is accelerating at +415.8% year-over-year, exceeding the 5-year CAGR of +16.4%. TTM revenue reached $15M. Growth momentum has increased versus prior periods.
What is AHG's long-term revenue growth rate?
Akso Health Group's 5-year revenue CAGR of +16.4% reflects the sustained expansion pattern. Current YoY growth of +415.8% is above this long-term average.
How is AHG's revenue distributed by segment?
AHG reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2015-2025 are available for download. Segment mix reveals concentration and diversification trends.